Definitive Healthcare Corp. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2023 Annual Meeting of Stockholders held by Definitive Healthcare Corp. (NASDAQ: DH) on June 1, 2023. The record date for voting was April 3, 2023, with 110,162,665 shares of Class A common stock and 44,218,741 shares of Class B common stock issued and outstanding.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity metrics, as this report focuses solely on corporate governance and voting results.
Material Changes and Voting Results
Stockholders voted on three proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): Four Class II directors were elected to serve three-year terms expiring in 2026.
- Chris Egan: 141,973,375 For; 2,930,251 Withhold.
- Samuel A. Hamood: 142,001,523 For; 2,902,103 Withhold.
- Jill Larsen: 130,600,677 For; 14,302,949 Withhold.
- Sastry Chilukuri: 143,372,138 For; 1,531,488 Withhold.
- Proposal 2 (Say-on-Pay Frequency): Stockholders approved, on a non-binding advisory basis, a one-year frequency for future advisory votes on executive compensation.
- 1 Year: 144,374,698 votes.
- 2 Years: 305,719 votes.
- 3 Years: 218,960 votes.
- Proposal 3 (Auditor Ratification): Stockholders ratified the selection of Deloitte & Touche LLP as the independent auditor for fiscal year 2023.
- For: 144,466,280 votes.
- Against: 2,468,804 votes.
Guidance, Outlook, and Management Commentary
Based on the advisory vote results, the Board of Directors determined that future advisory votes on executive compensation will be held annually until the next required frequency vote. The filing contains no financial guidance, risk disclosures, or unusual items.
Investor Verification Checklist
- Verify the specific terms and tenure of the newly elected Class II directors.
- Confirm the implementation of the annual executive compensation advisory vote schedule.
- Review the full proxy statement for detailed biographical information on the directors and the rationale behind the auditor selection.